1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Outcomesa

Overall (n = 28)Type
A (n = 5)B (n = 6)C (n = 4)D (n = 13)
Normal patency of ophthalmic arteryb
    Immediately after procedure24 (85.7)5 (100)5 (83.3)2 (50.0)12 (92.3)
    At 3 mo27 (96.4)5 (100)6 (100)4 (100)12 (92.3)
    At 12 mo27 (96.4)5 (100)6 (100)4 (100)12 (92.3)
Ophthalmic complications
    Retinal emboli5 (17.9)4 (80.0)001 (7.7)
    Optic atrophy3 (10.7)003 (75.0)0
New clinical symptoms11 (39.3)4 (80.0)1 (16.7)3 (75.0)3 (23.1)
    Transient6 (21.4)1 (20.0)1 (16.7)1 (25.0)3 (23.1)
    Permanent5 (17.9)3 (60.0)02 (50.0)0
  • a Values reported are count (percentage).

  • b Other cases had occlusion or slowed blood flow.